Back

A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R

30 April 2022 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 2 Thrombosis, Bleeding CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Ying Gue

Aintree University Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

69 More presentations in this session

Presentation thumbnail
Evidence of Sialylation pathways alteration in peripheral blood of Brugada Syndrome patients
Mrs A. Tarantino (Milan, IT)
Abstract
Presentation thumbnail
Autopsy and genetic characterization of juvenile sudden cardiac arrest and death: the ToRSADE experience
Doctor V. Spinelli (Florence, IT)
Abstract
Presentation thumbnail
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
Miss N. Kaur (Manchester, GB)
Abstract
Presentation thumbnail
Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials
Doctor E. Greca (Miami, US)
Abstract
Presentation thumbnail
Dissection of the role of microRNAs in cardiac fibrosis through functional genomics screenings
Doctor M. Mano (Coimbra, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources